Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma

Histology and Histopathology

Volumn 15, Issue 3, 2000, Pages 721-727

  Ioachim, E ^a   Charchanti, A ^a   Stavropoulos, N E ^a   Skopelitou, A ^a   Athanassiou, E D ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Bladder cancer; c erbB 2; HL DR; MDM2; p53; Rb

Indexed keywords

HLA DR ANTIGEN; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTOR, ERBB-2; RETINOBLASTOMA PROTEIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0033913253     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. TNM Classification
2. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
3. Loss of heterozygosity at the Rb locus is frequent and correlates with muscle invasion in bladder carcinoma
4. Histologic grading of transitional cell tumours of the bladder: Value of histologic grading (WHO) in prognosis
5. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia
6. Alterations of tumour suppressor genes in bladder cancer
7. Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer
8. The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients
9. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erbB-2. A study in Greek patients
10. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
11. Inhibition of apoptosis by the retinoblastoma gene product
12. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
13. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
14. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections
15. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: Correlation with tumor proliferation and oestrogen receptor status
16. Inactivation of the retinoblastoma susceptibility gene in human breast cancer
17. Altered patterns of Mdm2 and Tp53 expression in human bladder cancer
18. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc kinase
19. Over-expression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value
20. Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer
21. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer
22. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
23. p53 and erb-2 protein overexpression are associated with early invasion and metastasis in bladder cancer
24. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer
25. Is heterogeneous expression of HLA-DR antigens and CEA along with DNA profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?
26. An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma
27. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study
28. p53 and c-jun expression in urinary bladder transitional cell carcinoma: Correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage
29. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression
30. Growth fractions in bladder cancer defined by Ki-67: Association with cancer grade, category and recurrence rate of superficial lesions
31. Repression of p53-mediated transcription by MDM2: A dual mechanism
32. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder
33. Tumor suppressor genes
34. Immunoperoxidase staining for Ia-like antigens in paraffin embedded tissues from melanoma and lung carcinoma
35. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: Correlation with Ki-67 index
36. Interaction between the retinoblastoma protein and the oncoprotein MDM2
37. HLA class II sublocus expression in benign and malignant breast epithelium